Fixed Competitive Price Nopyl Acetate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

We thinks what customers think, the urgency of urgency to act in the interests of a customer position of principle, allowing for better quality, lower processing costs, prices are more reasonable, won the new and old customers the support and affirmation for 2-Bromofluorene, Guanfacine Hydrochloride, 4-Bromobenzaldehyde, Our concept is to help presenting the confidence of each buyers with the offering of our most sincere service, and the right product.

Fixed Competitive Price Nopyl Acetate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex Detail:

Product Detail

Name	Desmopressin
CAS number	16679-58-6
Molecular formula	C46H64N14O12S2
Molecular weight	1069.22
EINECS Number	240-726-7
Specific rotation	D25 +85.5 ± 2° (calculated for the free peptide)
Density	1.56±0.1 g/cm3(Predicted)
RTECS No.	YW9000000
Storage conditions	Store at 0°C
Solubility	H2O:soluble20mg/mL, clear, colorless
Acidity coefficient	(pKa) 9.90±0.15 (Predicted)

Synonyms

MPR-TYR-PHE-GLN-ASN-CYS-PRO-D-ARG-GLY-NH2; MINIRIN; [DEAMINO1, DARG8] VASOPRESSIN; [DEAMINO-CYS1, D-ARG8]-VASOPRESSIN; DDAVP, HUMAN; DESMOPRESSIN; DESMOPRESSIN, HUMAN; DESAMINO-[D-ARG8] VASOPRESSIN

Indications

(1) Treatment of central diabetes insipidus. After the drug can reduce urinary excretion, reduce urinary frequency and reduce nocturia.

(2) Treatment of nocturnal enuresis (patients aged 5 years or older).

(3) Test the renal urine concentration function, and carry out the differential diagnosis of renal function.

(4) For hemophilia and other bleeding diseases, this product can shorten the bleeding time and prevent bleeding. It can reduce the amount of intraoperative blood loss and postoperative oozing; especially in conjunction with reasonably controlled blood pressure during surgery, it can reduce intraoperative bleeding from different mechanisms, and reduce postoperative oozing, which can play a better role in blood protection.

Treatment of diabetes insipidus

Diabetes insipidus is primarily a disorder of water metabolism characterized by excess urine output, polydipsia, hypoosmolarity, and hypernatremia. Partial or complete deficiency of vasopressin (central diabetes insipidus), or renal insufficiency of vasopressin (nephrogenic diabetes insipidus) can be onset. Clinically, diabetes insipidus is similar to primary polydipsia, a condition in which excessive fluid intake is caused by a malfunction of the regulatory mechanism or abnormal thirst. Contrary to primary polydipsia, the increase in water intake in patients with diabetes insipidus is a corresponding response to changes in osmotic pressure or blood volume.

Product detail pictures:

Related Product Guide:

We've numerous great employees customers excellent at promoting, QC, and working with kinds of troublesome difficulty inside the generation method for Fixed Competitive Price Nopyl Acetate - Desmopressin Acetate to Treat central Diabetes Insipidus – Gentolex , The product will supply to all over the world, such as: Hyderabad, Zimbabwe, Frankfurt, Meanwhile, we're building up and consummating triangle market & strategic cooperation in order to achieve a multi-win trade supply chain to expand our market vertically and horizontally for a brighter prospects. development. Our philosophy is to create cost-effective products, promote perfect services, cooperate for long-term and mutual benefits, firm a comprehensive mode of excellent suppliers system and marketing agents, brand strategic cooperation sales system.

303-98-0